These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1848881)

  • 21. Detection and clinical associations of autoantibodies to myeloid granular proteins.
    Tervaert JW
    Adv Exp Med Biol; 1993; 336():299-302. PubMed ID: 8296621
    [No Abstract]   [Full Text] [Related]  

  • 22. Towards standard sera for the determination of anti-neutrophil cytoplasmic (ANCA) and anti-myeloperoxidase (aMPO) antibodies.
    Kallenberg CG; Tervaert JW; Huitema MG; van der Giessen M
    APMIS Suppl; 1989; 6():14-5. PubMed ID: 2544214
    [No Abstract]   [Full Text] [Related]  

  • 23. Myeloperoxidase specific anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA).
    Falk RJ; Hogan SL; Wilkman AS; Terrell RS; Lauritzen S; Charles LA; Jennette JC
    Neth J Med; 1990 Apr; 36(3-4):121-5. PubMed ID: 2162486
    [No Abstract]   [Full Text] [Related]  

  • 24. Autoantibodies to leucocyte antigens in hydralazine-associated nephritis.
    Almroth G; Eneström S; Hed J; Samuelsson I; Sjöström P
    J Intern Med; 1992 Jan; 231(1):37-42. PubMed ID: 1310098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern.
    Segelmark M; Baslund B; Wieslander J
    Clin Exp Immunol; 1994 Jun; 96(3):458-65. PubMed ID: 7516271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
    Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
    Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of myeloperoxidase and elastase enzyme activity with the antihypertensive agents hydralazine and dihydralazine.
    Hansson AL; Nässberger L
    Pharmacol Toxicol; 1993 Aug; 73(2):75-8. PubMed ID: 8248010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): specificity and clinical associations.
    Lesavre P; Noël LH; Gayno S; Nusbaum P; Reumaux D; Erlinger S; Grünfeld JP; Halbwachs-Mecarelli L
    J Autoimmun; 1993 Apr; 6(2):185-95. PubMed ID: 8388691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An ELISA for the detection of anti-neutrophil cytoplasm antibodies (ANCA).
    Rasmussen N; Sjölin C; Isaksson B; Bygren P; Wieslander J
    J Immunol Methods; 1990 Feb; 127(1):139-45. PubMed ID: 2156937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-myeloperoxidase antibodies and clinical associations.
    Daha MR; Falk RJ
    Neth J Med; 1990 Apr; 36(3-4):152-3. PubMed ID: 2162492
    [No Abstract]   [Full Text] [Related]  

  • 31. Antigen specificity in hydralazine associated ANCA positive systemic vasculitis.
    Short AK; Lockwood CM
    QJM; 1995 Nov; 88(11):775-83. PubMed ID: 8542262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-myeloperoxidase antibodies in systemic vasculitis.
    Lee SS; Adu D; Thompson RA
    Clin Exp Immunol; 1990 Jan; 79(1):41-6. PubMed ID: 2154347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-neutrophil cytoplasm antibodies in rheumatoid arthritis.
    Savige JA; Gallicchio MC; Stockman A; Cunningham TJ; Rowley MJ; Georgiou T; Davies D
    Clin Exp Immunol; 1991 Oct; 86(1):92-8. PubMed ID: 1655318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders.
    Tervaert JW; Mulder L; Stegeman C; Elema J; Huitema M; The H; Kallenberg C
    Ann Rheum Dis; 1993 Feb; 52(2):115-20. PubMed ID: 8383482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical investigation of anti-myeloperoxidase antibodies in patients with glomerulonephritis with crescent formation].
    Arimura Y; Nohmi K; Tanaka U; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1087-93. PubMed ID: 1962827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of ANCA isotype and affinity with disease expression.
    Esnault VL; Ronda N; Jayne DR; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):197-205. PubMed ID: 8499058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydralazine use can be associated with IgM-dominated immune complex-mediated glomerulonephritis.
    Zhang PL; Metcalf BD; Khan S; Abukhaled J; Zafar K; Li W; Kanaan HD
    Ultrastruct Pathol; 2024 Jul; 48(4):317-322. PubMed ID: 38685716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic significance of neutrophilic cytoplasmic antibodies in nephrology].
    Andrassy K; Koderisch J; Adler D
    Immun Infekt; 1990 Apr; 18(2):53-5. PubMed ID: 2190915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-idiotype antibodies to anti-myeloperoxidase autoantibodies in patients with systemic vasculitis.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):221-6. PubMed ID: 8388692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antineutrophil cytoplasm antibodies in Kawasaki disease.
    Savage CO; Tizard J; Jayne D; Lockwood CM; Dillon MJ
    Arch Dis Child; 1989 Mar; 64(3):360-3. PubMed ID: 2650637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.